BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 35696017)

  • 1. Structural and functional analysis of a potent human neutralizing antibody against enterovirus A71.
    Chen Z; Bao L; Zhu B; Fu H; Zhu S; Ji T; Xue Y; Liu C; Wang X; Li F; Lv Q; Qi F; Yu P; Deng W; Xu W; Qin C; Liu H; Jin Q
    Sci China Life Sci; 2022 Dec; 65(12):2517-2526. PubMed ID: 35696017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enterovirus A71 Containing Codon-Deoptimized VP1 and High-Fidelity Polymerase as Next-Generation Vaccine Candidate.
    Tsai YH; Huang SW; Hsieh WS; Cheng CK; Chang CF; Wang YF; Wang JR
    J Virol; 2019 Jul; 93(13):. PubMed ID: 30996087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody signatures in hospitalized hand, foot and mouth disease patients with acute enterovirus A71 infection.
    You L; Chen J; Cheng Y; Li Y; Chen YQ; Ying T; Turtle L; Yu H
    PLoS Pathog; 2023 Jun; 19(6):e1011420. PubMed ID: 37262073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a full-length cDNA-derived enterovirus A71 vaccine candidate using reverse genetics technology.
    Yang YT; Chow YH; Hsiao KN; Hu KC; Chiang JR; Wu SC; Chong P; Liu CC
    Antiviral Res; 2016 Aug; 132():225-32. PubMed ID: 27387826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Attenuated Enterovirus A71 Mutant with VP1-V238A,K244R Exhibits Reduced Efficiency of Cell Entry/Exit and Augmented Binding Affinity to Sulfated Glycans.
    Meng T; Wong SM; Chua KB
    J Virol; 2021 Oct; 95(22):e0105521. PubMed ID: 34468173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The stability and immunogenicity of formalin-inactivated Enterovirus A71 whole virion vaccine after ten years of low temperature storage.
    Shen YS; Chow YH; Fang CY; Wu SR; Chen CH; Huang MH; Liao CL; Chiang JR; Liu CC
    J Microbiol Immunol Infect; 2023 Dec; 56(6):1121-1128. PubMed ID: 37919172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel recombinant chimeric virus-like particle is immunogenic and protective against both enterovirus 71 and coxsackievirus A16 in mice.
    Zhao H; Li HY; Han JF; Deng YQ; Zhu SY; Li XF; Yang HQ; Li YX; Zhang Y; Qin ED; Chen R; Qin CF
    Sci Rep; 2015 Jan; 5():7878. PubMed ID: 25597595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune responses against enterovirus A71 infection: Implications for vaccine success.
    Aw-Yong KL; NikNadia NMN; Tan CW; Sam IC; Chan YF
    Rev Med Virol; 2019 Sep; 29(5):e2073. PubMed ID: 31369184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Polysaccharide Purified From
    Lin YL; Shih C; Cheng PY; Chin CL; Liou AT; Lee PY; Chiang BL
    Front Immunol; 2020; 11():561758. PubMed ID: 33117346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic Epidemiology and Phylodynamic Analysis of Enterovirus A71 Reveal Its Transmission Dynamics in Asia.
    Xiao J; Huang K; Lu H; Song Y; Han Z; Zhang M; Li J; Zhou X; Chen J; Yu Q; Yang M; Yan D; Ji T; Yang Q; Zhu S; Xu W; Zhang Y
    Microbiol Spectr; 2022 Oct; 10(5):e0195822. PubMed ID: 36200890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralization of African enterovirus A71 genogroups by antibodies to canonical genogroups.
    Volle R; Luo L; Razafindratsimandresy R; Sadeuh-Mba SA; Gouandjika-Valisache I; Horwood P; Duong V; Buchy P; Joffret ML; Huang Z; Duizer E; Martin J; Chakrabarti LA; Dussart P; Jouvenet N; Delpeyroux F; Bessaud M
    J Gen Virol; 2023 Nov; 104(11):. PubMed ID: 37909282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular epidemiology and clinical features of hand, foot and mouth disease requiring hospitalization after the use of enterovirus A71 inactivated vaccine in chengdu, China, 2017-2022: a descriptive study.
    Duan X; Zhang C; Wang X; Ren X; Peng H; Tang X; Zhang L; Chen Z; Ye Y; Zheng M; Zhong W; Chen X; Zeng Y; Yuan P; Long L
    Emerg Microbes Infect; 2022 Dec; 11(1):2510-2519. PubMed ID: 36103331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virulence of Enterovirus A71 Fluctuates Depending on the Phylogenetic Clade Formed in the Epidemic Year and Epidemic Region.
    Kobayashi K; Nishimura H; Mizuta K; Nishizawa T; Chu ST; Ichimura H; Koike S
    J Virol; 2021 Nov; 95(23):e0151521. PubMed ID: 34523967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence of genotype C1 Enterovirus A71 and its link with antigenic variation of virus in Taiwan.
    Huang KA; Huang PN; Huang YC; Yang SL; Tsao KC; Chiu CH; Shih SR; Lin TY
    PLoS Pathog; 2020 Sep; 16(9):e1008857. PubMed ID: 32936838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral activity of SP81 peptide against Enterovirus A71 (EV-A71).
    Abd-Aziz N; Lee MF; Ong SK; Poh CL
    Virology; 2024 Jan; 589():109941. PubMed ID: 37984152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine candidates generated by codon and codon pair deoptimization of enterovirus A71 protect against lethal challenge in mice.
    Lee MHP; Tan CW; Tee HK; Ong KC; Sam IC; Chan YF
    Vaccine; 2021 Mar; 39(12):1708-1720. PubMed ID: 33640144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Neutralizing Antibody Response Kinetics in Patients with Hand, Foot, and Mouth Disease Caused by Coxsackievirus A16 or Enterovirus A71: A Longitudinal Cohort Study of Chinese Children, 2017-2019.
    Zhou Y; Zhou J; Yang J; Qiu Q; Wang L; Yang J; Li Y; Liang L; Cui P; Cheng Y; Zheng W; Shi H; Gong H; Wang K; Zhou C; Chu JJH; Yu H
    J Immunol; 2022 Jul; 209(2):280-287. PubMed ID: 35777850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralizing antibody against Enterovirus-A71 in Thai children: A longitudinal study from birth to age 4 years.
    Puenpa J; Chansaenroj J; Auphimai C; Srimuan D; Thatsanathorn T; Poovorawan Y; Wanlapakorn N
    Vaccine; 2020 Nov; 38(48):7638-7644. PubMed ID: 33067033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis on epidemiological characteristics of enterovirus 71 cases of hand-foot-mouth disease based on the active monitoring in Guangdong Province in 2011-2015].
    Xie DS; He JF; Yang F; Li H; Kang M; Zhang M; Ye X; Tan XH; Ni XH; Hu L; Sun LM
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Jul; 52(7):738-742. PubMed ID: 29996302
    [No Abstract]   [Full Text] [Related]  

  • 20. Human Enterovirus 71 Protein Displayed on the Surface of Saccharomyces cerevisiae as an Oral Vaccine.
    Zhang C; Wang Y; Ma S; Li L; Chen L; Yan H; Peng T
    Viral Immunol; 2016 Jun; 29(5):288-95. PubMed ID: 27259043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.